Abstract

P-375 Perioperative FLOT in locally advanced and gastroesophageal junction cancer: A real-word experience in Argentina

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Palliative care for patients with gastroesophageal cancer at all stages: a narrative review.
Khaldoun Almhanna ... Kathryn Decarli
Annals of palliative medicine | VOL. 0
Khaldoun Almhanna, et. al.Khaldoun Almhanna ... Kathryn Decarli
01 Jan 2023
Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy.
Marton Erdos ... Aurel Ottlakan
Frontiers in surgery | VOL. 10
Marton Erdos, et. al.Marton Erdos ... Aurel Ottlakan
03 Apr 2023
Systematic Review and Meta- Analysis of Randomized Controlled Trials on Primary Outpatient Thromboprophylaxis (POTP) in Patients with Gastric and Gastro-Esophageal Junction (GEJ) Cancers Receiving Chemotherapy
Yin Mon Myat ... Kyaw Zin Thein
Blood | VOL. 140
Yin Mon Myat, et. al.Yin Mon Myat ... Kyaw Zin Thein
15 Nov 2022
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
... Tomasz Olesiński
The Lancet | VOL. 392
, et. al. ... Tomasz Olesiński
04 Jun 2018
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: “ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe”, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
H Li ... E Song
Annals of Oncology | VOL. -
H Li, et. al.H Li ... E Song
01 May 2024
View more papers